Comparison of Frequency of Use of Optive and Systane

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00406510
First received: November 30, 2006
Last updated: May 30, 2007
Last verified: May 2007
  Purpose

The purpose of this study is subjectively compare duration of action between Optive and Systane.


Condition Intervention Phase
Dry Eye
Drug: Optive, Systane
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind

Further study details as provided by Innovative Medical:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Males or females > 18 years old
  • Mild to moderate dry eye symptoms
  • Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
  • Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months,
  • Active ocular allergies
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00406510

Locations
United States, California
Private Practice
Azusa, California, United States, 91702
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Milton Hom, OD Private Practice
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00406510     History of Changes
Other Study ID Numbers: 5283
Study First Received: November 30, 2006
Last Updated: May 30, 2007
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 23, 2014